InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Stoke Therapeutics, Inc.

STOK Clue Score65
United States Fiscal year ends December CIK 0001623526 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
Jonathan Allan
18 Aug 2026
General Counsel & Corp Sec
Sell
145
$32.47
$4.71K
Jonathan Allan
18 Aug 2026
General Counsel & Corp Sec
Sell
2,716
$32.01
$86.93K
Edward M. MD Kaye
18 Aug 2026
Director
Sell
637
$32.47
$20.68K
Edward M. MD Kaye
18 Aug 2026
Director
Sell
11,930
$32.01
$381.85K
Barry Ticho
18 Aug 2026
Chief Medical Officer
Sell
242
$32.47
$7.86K
Barry Ticho
18 Aug 2026
Chief Medical Officer
Sell
4,525
$32.01
$144.83K
Jonathan Allan
18 Mar 2026
General Counsel & Corp Sec
Sell
72
$32.85
$2.37K
Jonathan Allan
18 Mar 2026
General Counsel & Corp Sec
Sell
334
$31.79
$10.62K
Jonathan Allan
18 Mar 2026
General Counsel & Corp Sec
Sell
4,222
$31.28
$132.08K
Jason Hoitt
18 Mar 2026
Chief Patient Officer
Sell
30
$32.85
$985.50
Jason Hoitt
18 Mar 2026
Chief Patient Officer
Sell
139
$31.79
$4.42K
Jason Hoitt
18 Mar 2026
Chief Patient Officer
Sell
1,762
$31.28
$55.12K
Thomas Leggett
18 Mar 2026
Chief Financial Officer
Sell
37
$32.85
$1.22K
Thomas Leggett
18 Mar 2026
Chief Financial Officer
Sell
172
$31.79
$5.47K
Thomas Leggett
18 Mar 2026
Chief Financial Officer
Sell
2,173
$31.28
$67.98K
Jonathan Allan
17 Mar 2026
General Counsel & Corp Sec
Sell
1,791
$33.38
$59.78K
Jonathan Allan
17 Mar 2026
General Counsel & Corp Sec
Sell
2,476
$32.74
$81.06K
Jason Hoitt
17 Mar 2026
Chief Patient Officer
Sell
748
$33.38
$24.96K
Jason Hoitt
17 Mar 2026
Chief Patient Officer
Sell
1,033
$32.74
$33.82K
Thomas Leggett
17 Mar 2026
Chief Financial Officer
Sell
922
$33.38
$30.77K
Thomas Leggett
17 Mar 2026
Chief Financial Officer
Sell
1,274
$32.74
$41.71K
Jonathan Allan
3 Dec 2025
General Counsel & Corp Sec
Sell
1,394
$30.85
$43.00K
Jonathan Allan
3 Dec 2025
General Counsel & Corp Sec
Sell
898
$30.34
$27.24K
Edward M. MD Kaye
3 Dec 2025
Director
Sell
651
$30.85
$20.08K
Edward M. MD Kaye
3 Dec 2025
Director
Sell
419
$30.34
$12.71K
Barry Ticho
3 Dec 2025
Chief Medical Officer
Sell
1,225
$30.85
$37.79K
Barry Ticho
3 Dec 2025
Chief Medical Officer
Sell
789
$30.34
$23.94K
Jonathan Allan
2 Dec 2025
General Counsel & Corp Sec
Sell
868
$30.14
$26.16K
Jonathan Allan
2 Dec 2025
General Counsel & Corp Sec
Sell
1,416
$29.56
$41.86K
Edward M. MD Kaye
2 Dec 2025
Director
Sell
405
$30.14
$12.21K
Edward M. MD Kaye
2 Dec 2025
Director
Sell
661
$29.56
$19.54K
Barry Ticho
2 Dec 2025
Chief Medical Officer
Sell
762
$30.14
$22.97K
Barry Ticho
2 Dec 2025
Chief Medical Officer
Sell
1,244
$29.56
$36.78K
Show all 81 transactions →

What was left out

Form 4 filings counted 54
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 2
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 261,194
History held since 20 Jun 2019